Myrexis, Inc. (NASDAQ:MYRX)
| CAPS Rating |
|
|---|---|
| Open | $2.73 |
| Previous Close | $2.81 |
| Daily Range | $2.73 - $2.83 |
| 52-Week Range | $2.41 - $4.52 |
| Market Cap | $73.30M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | 65.00 (N/A) |
| Volume | 22,875 |
| Average Daily Volume | 0 |
MYRX
VS S&P 500 (SPY)
How do you think MYRX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MYRX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MYRX News and Commentary
- Bullish Insiders: Top 5 Insider Buys at Companies Reporting Earnings Next Week – The Motley Fool
- Bullish Insiders: Top 5 Insider Buys At Companies Reporting Earnings Next Week – NASDAQ
- 16 Small Caps With Cash to Cover 1+ Years of Operating Expenses – SeekingAlpha
- Myrexis: Significantly Unknown and Undervalued – SeekingAlpha
- Fresh bottoms for the grabbing – Blog at The Motley Fool
Related News and Articles
- Illuminating the Way Forward for Genomics – The Motley Fool
- When Passing Your Clinical Trial Isn't Enough – The Motley Fool
- This Just In: More Upgrades and Downgrades – The Motley Fool
- Life Technologies' Sequence of Success – The Motley Fool
- Is Avanir Pharmaceuticals the Perfect Stock? – The Motley Fool
- Can Amgen Convince Docs to Recommend Approval? – The Motley Fool
- Why Did My Stock Just Die? – The Motley Fool
- Curing Diseases Makes For a Bad Business Model – The Motley Fool
- Idenix Pharmaceuticals Shares Dropped: What You Need to Know – The Motley Fool
- What's Going on With These Biotech Stocks? – The Motley Fool
- Gilead Sciences Shares Surged: What You Need to Know – The Motley Fool
- Has Elan Become the Perfect Stock? – The Motley Fool
- Whoa! What Just Happened to My Stock? – The Motley Fool
RSS Headlines
Fool UK
